Hands-On With The Scanadu Scout, The Health Gadget That's Crowdfunding Its Way To FDA Approval
Hands-On With The Scanadu Scout, The Health Gadget That's Crowdfunding Its Way To FDA Approval
                               

Comments:

Related:

Amazon's cloud services cleared for US government use
The high-tech world of homebrew e-cigarette designers

Here's How The First FDA-Approved Bionic Eye Works

www.businessinsider.com
Second Sight is a company that has developed a groundbreaking piece of technology called the Argus II. Basically, it's an eye implant connected to a pair of glasses that restore vision to patients who are blinded by a disease called retinitis pigmentosa, which has damaged the retina tissue of around...
Here's How The First FDA-Approved Bionic Eye Works

The White House opens the data floodgates, and now the real work will begin

gigaom.com
President Obama on Thursday signed an executive order making open data the default policy for the federal government. This is a hugely significant move, although one that can and will have its openness and thus, significance, chipped away over time. But it’s a good start. While we may never get...
The White House opens the data floodgates, and now the real work will begin

RP-VITA bringing its telepresence to seven North American hospitals

www.engadget.com
We've already seen the RP-VITA in action -- and so, for that matter, has the FDA. Now iRobot / InTouch Health's telepresence 'bot is ready to take the field. The companies today jointly unveiled a list of seven US and Mexican hospitals that will be using the iPad-friendly wheeled...
RP-VITA bringing its telepresence to seven North American hospitals
Jawbone launches an API and acquires BodyMedia, and the connected device landscape continues to take shape
Fake malaria drugs might soon be spotted, thanks to handheld device
Stanford team shows how doctors' notes can spot problem drugs
FDA investigating safety of widely-used surgical robot following increased incident reports
× Just a test of the new info bar. What do you think?